![Eddie A Hjerpe](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Eddie A Hjerpe
Directeur/Membre du Conseil chez
Velentium LLC
Profil
Eddie Hjerpe currently works at Great Point Partners Private Equity, as Senior Vice President from 2021, Tergus Pharma LLC, as Board Member from 2019, Velentium LLC, as Board Member from 2021, and Performance Cell Manufacturing, Inc., as Board Member from 2022.
Mr. Hjerpe also formerly worked at Catalent MSTC, Inc., as Board Member from 2019 to 2020.
Mr. Hjerpe received his undergraduate degree and graduate degree from the University of Notre Dame.
Postes actifs de Eddie A Hjerpe
| Sociétés | Poste | Début |
|---|---|---|
Great Point Partners Private Equity
 Great Point Partners Private Equity Investment ManagersFinance Great Point Partners invests in companies located in the United States, Canada and Western Europe with an EBITDA ranging from USD 2 - 12 million and revenue ranging from USD 10 - 100 million. The firm targets companies operating in the fields of healthcare sectors and industries. It provides financing for buyout and growth capital requirements with an investment size ranging from USD 10 - 100 million. The firm acquires minority and majority interests and also acts as lead investor. | Private Equity Investor | 01/01/2020 |
Performance Cell Manufacturing, Inc.
 Performance Cell Manufacturing, Inc. BiotechnologyHealth Technology Manufactures cell and gene therapies | Directeur/Membre du Conseil | 01/01/2022 |
Velentium LLC
 Velentium LLC Medical SpecialtiesHealth Technology Designs and manufactures therapeutic & diagnostic medical devices and provides engineering services | Directeur/Membre du Conseil | 01/09/2021 |
Tergus Pharma LLC
 Tergus Pharma LLC Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical research, drug development, testing and manufacturing company | Directeur/Membre du Conseil | 01/06/2019 |
Anciens postes connus de Eddie A Hjerpe
| Sociétés | Poste | Fin |
|---|---|---|
Catalent MSTC, Inc.
 Catalent MSTC, Inc. Medical SpecialtiesHealth Technology Engages in third party contract manufacturing for cell therapy companies | Directeur/Membre du Conseil | 28/02/2020 |
Formation de Eddie A Hjerpe
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
18
Relations au 1er degré
6
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
University of Notre Dame
 University of Notre Dame Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Great Point Partners Private Equity
Great Point Partners Private Equity Investment ManagersFinance Great Point Partners invests in companies located in the United States, Canada and Western Europe with an EBITDA ranging from USD 2 - 12 million and revenue ranging from USD 10 - 100 million. The firm targets companies operating in the fields of healthcare sectors and industries. It provides financing for buyout and growth capital requirements with an investment size ranging from USD 10 - 100 million. The firm acquires minority and majority interests and also acts as lead investor. | Finance |
Tergus Pharma LLC
Tergus Pharma LLC Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical research, drug development, testing and manufacturing company | Health Technology |
Catalent MSTC, Inc.
Catalent MSTC, Inc. Medical SpecialtiesHealth Technology Engages in third party contract manufacturing for cell therapy companies | Health Technology |
Velentium LLC
Velentium LLC Medical SpecialtiesHealth Technology Designs and manufactures therapeutic & diagnostic medical devices and provides engineering services | Health Technology |
Performance Cell Manufacturing, Inc.
Performance Cell Manufacturing, Inc. BiotechnologyHealth Technology Manufactures cell and gene therapies | Health Technology |
